納微科技(688690.SH):上半年淨利預增147.40%至172.55%
格隆匯6月30日丨納微科技(688690.SH)公佈,經財務部門初步測算,預計2021年半年度實現營業收入1.59億元至1.7億元,較上年同期相比,將增加人民幣8074.49萬元至9274.49萬元,同比增長103.18%至118.52%。
預計2021年半年度實現歸屬於母公司所有者的淨利潤5900萬元至6500萬元,較上年同期相比,將增加人民幣3515.16萬元至4115.16萬元,同比增長147.40%至172.55%。
預計2021年半年度實現扣除非經常性損益後歸屬母公司所有者的淨利潤5500萬元至6100萬元,較上年同期相比,將增加人民幣3509.24萬元至4109.24萬元,同比增長176.28%至206.42%。
我國生物製藥產業快速發展,對性能優異、供應穩定、價格合理的國產分離純化色譜填料和層析介質產品產生了迫切需求。公司依託納米微球底層製備技術創新優勢,已積累形成較齊全的產品種類和豐富的客户基礎,支撐了公司業績的快速增長。本期內大分子生物藥物用親和層析介質、離子交換層析介質等產品的銷售較上年同期有較大幅度增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.